skip to main content

    Updated Visitor Guidelines

 

MENU

 

Few patients receive recommended genetic testing after cancer diagnosis

Among more than a million patients with cancer, only 6.8% underwent germline genetic testing — an analysis of inherited genes — within two years of diagnosis, according to the study published June 5 in the Journal of the American Medical Association.

Program gives undergrads a ‘pathway’ to cancer careers

The Rogel Cancer Center’s Pathways Undergraduate Fellowship program launched in 2022 to fill a gap in training programs that left out undergraduate students from across Michigan. Pathways is aimed at students from Michigan universities excluding U-M’s Ann Arbor campus. It’s for students who might have some interest in careers in science or cancer but who aren’t fully committed.

Literature suggests dietary changes contribute to healthy gut microbiota and weight loss

In an invited review article recently published in the medical journal, “Current Opinion in Clinical Nutrition and Metabolic Care,” Research Professor Zora Djuric, Ph.D. of the Department of Family Medicine found that by including more fiber, plant-based foods, omega-3 fatty acids and whole grains, people can mitigate the adverse health effects of high fat diets and obesity on their microbiome.

MI-CARES

Celeste Leigh Pearce, Ph.D., M.P.H. wants to build more than a cohort of study participants. She wants to create a movement. It’s a movement to understand how exposures to toxic metals, industrial pollution and “forever chemicals” called PFAS are impacting the health and cancer risk of residents across Michigan.

COVID, collaboration and cancer care

When the pandemic hit, Rogel researchers, clinicians and staff needed to rethink how they did their work. In doing so, they discovered new ways to fulfill the cancer center’s mission despite unprecedented uncertainty.

Circulating biomarkers: Hitting the mark

Circulating biomarkers, a new frontier in cancer care, bring both hope and unease to the clinic. Rogel researchers are unraveling their nuances, advancing enabling technologies, advocating for patients and figuring out how to ethically integrate this technology into clinical care.

The hope of metabolic pathways in cancer research

Advances in the lab like improved measurement of metabolism in tumors using PET scans, mass spectrometry and stable isotope tracing, the development of new and better drugs that can block metabolic pathways in cancer and a deeper understanding of the relationship between metabolism and the immune system all point to real hope that the time is now to target metabolism to improve cancer therapy, especially in those forms of cancer that don’t respond well to current treatments.

Pages